Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses

American Journal of Gastroenterology

Volumn 101, Issue 8, 2006, Pages 1834-1840

  Melmed, Gil Y ^a   Ippoliti, Andrew F ^a   Papadakis, Konstantinos A ^a   Tran, Tram T ^a   Birt, Jaime L ^a   Lee, Susie K ^a   Frenck, Robert W ^b,c   Targan, Stephan R ^a   Vasiliauskas, Eric A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; HEPATITIS VACCINE; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; VACCINE;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD SAMPLING; CHICKENPOX; ENTERITIS; FEMALE; HEALTH EDUCATION; HEALTH SURVEY; HEPATITIS A; HEPATITIS B; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION RISK; INFLUENZA; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; STREPTOCOCCUS INFECTION; TETANUS PROPHYLAXIS; UNSPECIFIED SIDE EFFECT; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; CHICKENPOX; CHRONIC DISEASE; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNIZATION; IMMUNOCOMPROMISED HOST; INFLAMMATORY BOWEL DISEASES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; QUESTIONNAIRES; RISK FACTORS;

EID: 33746762920     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00646.x     Document Type: Article

References (36)

1. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005;307:1920-5.
2. Baghai M, Osmon DR, Wolk DM, et al. Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Mayo Clin Proc 2001;76:653-6.
3. Ostuni P, Botsios C, Punzi L, et al. Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate. Ann Rheum Dis 2003;62:686-7.
4. Vonkeman H, ten Napel C, Rasker H, et al. Disseminated primary varicella infection during infliximab treatment. J Rheumatol 2004;31:2517-8.
5. Michel M, Duvoux C, Hezode C, et al. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease. J Rheumatol 2003;30:1624-5.
6. Deutsch DE, Olson AD, Kraker S, et al. Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine. J Pediatr Gastroenterol Nutr 1995;20:351-3.
7. Bernal I, Domenech E, Garcia-Planella E, et al. Opportunistic infections in patients with inflammatory bowel disease undergoing immunosuppressive therapy. Gastroenterol Hepatol 2003;26:19-22.
8. Lemyze M, Tavernier JY, Chevalon B, et al. Severe varicella zoster pneumonia during the course of treatment with azathioprine for Crohn's disease. Rev Mal Respir 2003;20:773-6.
9. Leung VS, Nguyen MT, Bush TM. Disseminated primary varicella after initiation of infliximab for Crohn's disease. Am J Gastroenterol 2004;99:2503-4.
10. Ritz MA, Jost R. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease. Inflamm Bowel Dis 2001;7:327.
11. Vergara M, Brullet E, Campo R, et al. Fulminant infection caused by varicella herpes zoster in patient with Crohn disease undergoing treatment with azathioprine. Gastroenterol Hepatol 2001;24:47.
12. Foster KJ, Devitt N, Gallagher PJ, et al. Overwhelming pneumococcal septicaemia in a patient with ulcerative colitis and splenic atrophy. Gut 1982;23:630-2.
13. Keene JK, Lowe DK, Grosfeld JL, et al. Disseminated varicella complicating ulcerative colitis. JAMA 1978;239:45-6.
14. Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 1993;42:1-18.
15. Sands BE, Cuffari C, Katz J, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2004;10:677-92.
16. Harper SA, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2004;53:1-40.
17. Esteve M, Saro C, Gonzalez-Huix F, et al. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: Need for primary prophylaxis. Gut 2004;53:1363-5.
18. Update on adult immunization. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991;40:1-94.
19. www.cdc.gov/nip/recs/adult-schedule.htm#print. Accessed December 14, 2004.
20. Duchini A, Goss JA, Karpen S, et al. Vaccinations for adult solid-organ transplant recipients: Current recommendations and protocols. Clin Microbiol Rev 2003;16:357-64.
21. Davies K, Woo P. Immunization in rheumatic diseases of childhood: An audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology (Oxford) 2002;41:937-41.
22. Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000;30:857-69.
23. Bridges MJ, Coady D, Kelly CA, et al. Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:685.
24. Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48:1-5.
25. Wagner D, Wagenbreth I, Stachan-Kunstyr R, et al. Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients. Clin Investig 1992;70:585-7.
26. Donati M, Zuckerman M, Dhawan A, et al. Response to varicella immunization in pediatric liver transplant recipients. Transplantation 2000;70:1401-4.
27. Sanchez-Fructuoso AI, Prats D, Naranjo P, et al. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: Mycophenolate versus azathioprine. Transplantation 2000;69:436-9.
28. Giebink GS, Warkentin PI, Ramsay NK, et al. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis 1986;154:590-6.
29. Bennett RG, Powers DC, Remsburg RE, et al. Hepatitis B virus vaccination for older adults. J Am Geriatr Soc 1996;44:699-703.
30. Yu AS, Cheung RC, Keeffe EB. Hepatitis B vaccines. Clin Liver Dis 2004;8:283-300.
31. Lin PL, Michaels MG, Green M, et al. Safety and immunogenicity of the American Academy of Pediatrics - recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Pediatrics 2005;116:160-7.
32. MacDonald R, Baken L, Nelson A, et al. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999;16:173-7.
33. Elkayam O, Caspi D, Reitblatt T, et al. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2004;33:283-8.
34. Mease PJ, Ritchlin CT, Martin RW, et al. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 2004;31:1356-61.
35. Fomin I, Caspi D, Levy V, et al. Vaccination against influenza in rheumatoid arthritis: The effect of disease modifying drugs, including TNF a blockers. Ann Rheum Dis 2006;65:191-4.
36. Kapetanovic MC, Saxne T, Sjoholm A, et al. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 2006;45:106-11.